» Articles » PMID: 35204546

Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential

Overview
Specialty Radiology
Date 2022 Feb 25
PMID 35204546
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a multifactorial, irreversible age- and obesity-induced joint degenerative disease, with an increasing incidence in developed countries. With a pathophysiology and etiology that are currently under-investigated, the only available disease-modifying treatment relies solely on total joint arthroplasty, which entails major economic burdens. Recently, the research focus has shifted towards the evaluation of metabolically active mediators secreted by the adipose tissue, which could be potential targets for a better understanding of the mechanisms involved in OA onset and development. Of note, adiponectin has drawn a great deal of attention, since it is the most abundant type of circulating adipokine and has been highly associated with OA occurrence. Thus far, studies have been controversial in establishing whether adiponectin possesses a destructive or protective role in OA development. Therefore, we critically and systematically reviewed, herein, the roles of adiponectin in the pathophysiology of OA, the link between obesity, adiponectin expression and the progression of OA, as well as its potential role as a future biomarker for a more optimized and reliable diagnosis of this degenerative disorder.

Citing Articles

Autophagy: regulating the seesaw of bone-fat balance.

Zhang B, Cui J, Zhang X, Pan Z, Du L, Ye R Front Cell Dev Biol. 2025; 13:1465092.

PMID: 40066259 PMC: 11891371. DOI: 10.3389/fcell.2025.1465092.


The Expression Level of SOX Family Transcription Factors' mRNA as a Diagnostic Marker for Osteoarthritis.

Baran K, Brzezianska-Lasota E, Kryczka J, Boncela J, Czechowska A, Kopacz K J Clin Med. 2025; 14(4).

PMID: 40004707 PMC: 11856735. DOI: 10.3390/jcm14041176.


Associations between body composition, metabolic mediators and osteoarthritis in cats.

Ley C, M Strage E, Stadig S, von Bromssen C, Olsson U, Bergh A BMC Vet Res. 2025; 21(1):103.

PMID: 40001060 PMC: 11853884. DOI: 10.1186/s12917-025-04536-y.


Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis.

Zhang Q, Zhao Y, Li L, Fan Q, Huang B, Du H J Inflamm Res. 2025; 18:1207-1233.

PMID: 39886385 PMC: 11780177. DOI: 10.2147/JIR.S499835.


Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis.

Zheng X, Li J, Ma Q, Gong J, Pan J BMC Med Genomics. 2025; 18(1):2.

PMID: 39748395 PMC: 11697936. DOI: 10.1186/s12920-024-02074-4.


References
1.
Pereira D, Ramos E, Branco J . Osteoarthritis. Acta Med Port. 2015; 28(1):99-106. DOI: 10.20344/amp.5477. View

2.
Tang C, Chiu Y, Tan T, Yang R, Fu W . Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol. 2007; 179(8):5483-92. DOI: 10.4049/jimmunol.179.8.5483. View

3.
Fang H, Judd R . Adiponectin Regulation and Function. Compr Physiol. 2018; 8(3):1031-1063. DOI: 10.1002/cphy.c170046. View

4.
Wluka A, Lombard C, Cicuttini F . Tackling obesity in knee osteoarthritis. Nat Rev Rheumatol. 2012; 9(4):225-35. DOI: 10.1038/nrrheum.2012.224. View

5.
Xie C, Chen Q . Adipokines: New Therapeutic Target for Osteoarthritis?. Curr Rheumatol Rep. 2019; 21(12):71. PMC: 7291783. DOI: 10.1007/s11926-019-0868-z. View